Abstract

The intravenous administration of dextran has previously been shown to produce a bleeding tendency in laboratory animals and in humans. Extensive studies concerning the hemostatic defect have yielded much useful information. Carbone, Furth, Scott and Crosby (1) found that the major abnormality consisted of a prolongation of the bleeding time. In seven of 11 patients given 1,500 to 6,500 ml. of dextran intravenously over a five day period the bleeding time was prolonged over 30 minutes. The concentration of platelets, clotting time, fibrinogen level, clot retraction time and prothrombin consumption test were not significantly affected by dextran. The prothrombin time was slightly abnormal. It appears unlikely that this finding explains the hemostatic defect because of the inconstancy and mild degree of the change. Adelson, Crosby and Roeder (2) found that smaller amounts of dextran were required to produce a prolonged bleeding time in dogs made thrombocytopenic by irradiation than in normal dogs. Comparable volumes of gelatin in the thrombocytopenic dogs did not prolong the

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.